Private practice with Dr Seth Bilazarian

View all posts »

Making sense of patient compliance

Nov 16, 2011 20:55 EST


The HOOPS and MI FREEE trials presented here at AHA 2011 delve into the enigma of patient compliance and present confounding results.

See:

 





« Previous Post
Calling all "bottom-feeder interventionalists" who provide PCI without SOS
Dec 13, 2011 10:25 EST Next post »
When to bridge patients on long-term anticoagulation
Nov 16, 2011 10:15 EST



Your comments
Making sense of patient compliance
# 1 of 2
November 20, 2011 08:59 (EST)
Dr Guy Wright-Smith

Thanks Seth,

Very insightful comments.

What do we have to do to get our patients to take the drugs we recommend?

Hope you are well.

Cheers

  
# 2 of 2
December 2, 2011 10:49 (EST)
Carolyn Thomas
Dr. Seth - it seems the headlines here may be confusing.  Instead of being shocked by the low adherence in the MI FREE study, why aren't cardiologists jumping all over the low (2%) absolute risk reduction differences observed in outcomes between the two groups?  "There was no significant between-group difference in the primary outcome (first major vascular event or revascularization) = 17.6 vs. 18.8 in the usual-coverage group.  I'm curious about why that is not worth exploring?

You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Forgot your username and/or password?
        Login        
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

    Join now for full access    
About Dr Seth Bilazarian
Seth Bilazarian MD has been a Clinical and Interventional Cardiologist at Pentucket Medical Associates in Massachusetts since 1993. He is board certified in Internal Medicine, Cardiovascular Medicine, Nuclear Cardiology, Vascular Ultrasound, Interventional Cardiology, and Vascular and Endovascular Medicine.

Dr Bilazarian performs coronary and peripheral interventions at Lahey Clinic and Massachusetts General Hospital. He has been an investigator in the interventional laboratory for new devices including drug-eluting stents, distal protection devices, imaging devices (OCT and InfraRed), and anticoagulant pharmacotherapy.

Dr Bilazarian is an active participant in clinical trials in congestive heart failure, hypertension, coronary disease prevention, prediabetes management, anemia, atrial fibrillation, and anticoagulation/antiplatelet therapies in the outpatient setting. He has authored numerous papers and book chapters in clinical cardiology. He was appointed as a physician advisor to the circulatory device panel of the FDA in 2008.
About this blog
My intent is to create a forum for dialogue on issues pertinent to private practice cardiology around topics such as:

  • Integration of new data and guidelines on inpatient and outpatient practice in clinical and interventional cardiology
  • Practice approaches to the extra clinical issues in dealing with managed care insurers
  • Strategies for navigating the restrictions of pharmacy benefits managers (PBMs) on pharmacologic therapies for our patients
  • Experiences with restrictions on testing and imaging
The video blog (VLOG) will provide an opportunity to share broadly different approaches to the common conundrums we face in caring for patients. My hope is that this forum will provide useful data points for practice outside of tertiary and academic centers and a look inside community hospitals and physician?s practice patterns in the office, starting with mine.